Trikafta (elexacaftor/ ivacaftir/tezacagtor) as the first triple combined therapy for CF mutation has been approved.
Posts Tagged ‘Triple Therapy to Treat Cystic Fibrosis Approved by FDA’
Trikafta (elexacaftor/ ivacaftir/tezacagtor) as the first triple combined therapy for CF mutation has been approved.